tymora-analytical 产品代理
tymora-analytical 产品代理
Tymora的技术已被国际公认为进行蛋白质组学和磷酸化分析的新颖、高效和成本效益高的方法。Tymora已获得多个NSF和NIH SBIR/STTR拨款，以进一步开发这些技术的新应用。
Tymora愿意与对我们的技术感兴趣的合作伙伴合作，用于设计和验证早期疾病检测测试、癌症治疗后监测，或用于管道治疗的配套诊断分析。
pIMAGO
PolyMAC
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow detection of active exosome protein and phosphoprotein cancer markers directly from plasma, urine or saliva. As a platform to discover, validate and routinely detect diagnostic markers, our unique approach offers enormous potential to find signaling proteins in biofluids that were not previously accessible.
Tymora’s technologies have been recognized internationally as novel, highly-effective and cost-efficient approaches to carry out proteomic and phosphorylation analyses. Tymora has received multiple NSF and NIH SBIR/STTR grants to further develop new applications of the technologies.
Tymora is open to collaborations with partners interested in our technology for design and validation of early disease detection tests, cancer monitoring post-treatment, or for companion diagnostic assays for pipeline therapies.
